Huntsman Cancer Institute established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Ignacio Garrido-Laguna, MD, PhD, is a physician-scientist who treats patients with pancreatic cancer.
Dr. Deborah Stephens cares for patients with lymphoma and chronic lymphocytic leukemia and researches these diseases. In this episode of Talks with Docs, she shares the importance of caring for the whole patient and how becoming a mom has changed her.
Thomas Varghese, MD, became interested in medicine at an early age. We ask him about what inspired his career and learn about his artistic talents outside of the operating room.
Every year, we open our doors to share our mission and educate our community about cancer prevention and research.
Everyone is at risk for skin cancer, no matter your skin color or type. Know the myths and facts about sun safety and protect your skin from the sun at every age.
Huntsman Cancer Institute (HCI) at the University of Utah has been recognized as one of the top cancer hospitals in the nation by U.S News and World Report for the third consecutive year.
The PathMaker program is a stepping stone for students interested in a career in health sciences or STEM with backgrounds underrepresented in the biomedical workforce.
Beat the end-of-summer blues by taking one last family field trip to the Leonardo Museum. In the City Blocks exhibit, you can see Huntsman Cancer Institute and other iconic buildings in Salt Lake City made entirely out of LEGO® bricks.
Study of Utah Lung Cancer Patients Finds Those Who Never Smoked May Have Genetic Predisposition for Cancer
Despite Utah's low smoking rate, lung cancer remains the leading cause of cancer death in Utah. In addition, lung cancer in people who have used tobacco and people who have never smoked behaves differently. Researchers at Huntsman Cancer Institute wanted to know why.
Huntsman Cancer Institute established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Howard Colman, MD, PhD is a physician-scientist specializing in the treatment of brain tumors and the diagnosis and management of neurologic complications of cancer.
The state of Huntsman Cancer Institute is strong and focused, according to CEO Mary Beckerle, PhD. The annual presentation to faculty, staff, and students is a chance for Dr. Beckerle to reflect on accomplishments of the prior year and outline priorities for the future.
Leaders from the Sigma Chi Fraternity, representing 37 chapters from across the nation, visited Huntsman Cancer Institute to dedicate the Sigma Chi Friendship Garden at the Primary Children’s and Families’ Cancer Research Center.
A group of 22 runners from 4K for Cancer-Ulman Cancer Fund visited Huntsman Cancer Institute for a tour and service project on June 29, 2018. The team, consisting of runners from all across the United States, is running 4,000 miles from San Francisco to New York this summer to raise money and awareness for young adults impacted by cancer.
Huntsman Cancer Institute established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Adam Cohen, MD, MS, was recently honored with a Huntsman Translational Scholar award. He is a researcher and physician, specializing in neuro-oncology and breast oncology.
With the news of Senator John McCain’s glioblastoma diagnosis, we asked the experts at Huntsman Cancer Institute about symptoms, diagnosis, and treatment of this cancer.
For tumors of the head and neck, surgery is often the first line of treatment. Head and neck surgical oncologists at Huntsman Cancer Institute perform the most complex procedures in the region for benign and malignant tumors of the thyroid, oral cavity, upper digestive tract, salivary glands, and other parts of the head and neck. Because these areas involve speech and swallowing, comprehensive care from an expert multidisciplinary team is crucial in decreasing complications and achieving the best possible outcomes for patients.
The second cancer conference for the Hispanic/Latino Community of Utah, Salud Para Mí, Es Salud Para Mi Familia 2018, took place Saturday, June 16, at Salt Lake Community College. The conference offers a space for the Hispanic/Latino community of Utah to receive screenings with local health care providers, get reliable health information, and learn about cancer screening and prevention.
Are you thinking about taking part in a clinical trial? Read these five frequently asked questions about clinical trials.
“Delivering Discoveries: Expanding the Reach of Precision Medicine,” was the theme of the American Society of Clinical Oncology (ASCO) 2018 annual meeting held June 1-5, 2018 in Chicago. One of the largest scientific conferences in the world, the meeting brings together nearly 40,000 attendees and features thousands of studies about new ways to prevent, detect, and treat cancer.
It is patients like you, your loved ones, and Dr. Gertz's parents who keep us motivated and excited to find ways to help in the fight against this terrible disease. We appreciate everything you do as patients—like donating samples and participating in clinical trials—and we want you to know that we are doing everything we can to help patients with breast and uterine cancer.